Postbiotic Market By Form (Powder, Liquid, Others), By Application (Personal Care and Cosmetics, Food and Beverage, Animal Feed, Pharmaceuticals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

The postbiotics market was valued at $1,579.0 million in 2021, and is estimated to reach $3,025.8 million by 2031, registering a CAGR of 6.8% from 2022 to 2031. In 2021, the powdered postbiotic segment accounted for the majority of the total postbiotic market. Postbiotics are soluble factors that provide physiological benefits to the host and are secreted by live bacteria or released after bacterial lysis. Metabiotics, biogenic, and metabolites are other names for postbiotics, and they are most commonly used as supplements and cosmetics.

The demand for various types of nutraceutical products is rapidly increasing. The primary reason for the increase in demand is growing awareness of the health benefits of using nutraceuticals and nutraceutical supplements. Furthermore, the adoption of hectic lifestyles due to work pressure, combined with increased consumption of fast and unhealthy foods, is driving consumers to seek out supplements that can help them maintain their health and well-being. Fast food consumption is increasing, which is causing diseases such as high cholesterol, obesity, bone degeneration, and heart disease. More and more people are engaging in fitness activities such as visiting gyms and athletic centers to maintain their health, and they are combining these activities with postbiotic nutraceuticals to achieve the best results.

Consumer lifestyle changes have been one of the major factors contributing to the growing popularity of functional foods and beverages in developing economies. Customers' food habits are changing in Asia-Pacific countries as per capita income rises. The rise in aspiration and preference for a luxurious lifestyle has resulted in a significant increase in market size and overall demand. Functional beverages are made up of specific nutrients and supplements, such as probiotics, which improve athletic performance and metabolism. Appropriate nutrition is a necessary prerequisite for effective athletic performance improvement, conditioning, recovery from fatigue after exercise, and rapid injury recovery. It also aids in the management of diabetes. As a result, the demand for functional beverages such as natural sports and energy drinks is rapidly increasing.

The difficulties that manufacturers face during the manufacturing process impede the postbiotic market. Many times, the extraction of the ingredients required to make postbiotics is difficult, and the end result is a very small amount of the ingredient. The ingredient's stability is also important, as many nutraceutical ingredients are highly unstable and decompose quickly in unfavorable conditions. As a result, these ingredients must be carefully stored and handled, which sometimes necessitates large investments in equipment. Furthermore, due to the various textures and forms of the ingredients, manufacturing postbiotics can be difficult at times, making it difficult for the engaged stakeholders to manufacture such types of nutraceuticals.

Postbiotics are becoming increasingly popular as more consumers add nutraceuticals to their regular diets. However, many consumers are looking for supplements that are both convenient and tasty, making such products easier to consume. Newer types of nutraceuticals, such as gummies, jellies, and soft gels, are being introduced to the market, and their popularity is growing. They come in a variety of shapes, sizes, flavors, and concentrations. Most of these nutraceuticals are intended for daily consumption, and thus these varieties allow consumers to consume these nutraceuticals on a daily basis if they are perceived to be enjoyable to consume. Furthermore, these types of nutraceuticals are becoming increasingly popular among children.

The postbiotic market is segmented on the basis of form, application, and region. By form, the postbiotic market is classified into powder, liquid, and others. Depending on the application, the market is categorized into personal care and cosmetics, food and beverage, animal feed, pharmaceuticals, and others. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players analyzed in this report are Sami-Sabinsa Group Limited, Woresan GmbH, Novachem SRL, ILDONG HOLDINGS CO., LTD., Church & Dwight Co., Inc., Danish Agro, Lamberti S.p.A., Cargill, Incorporated, Adare Pharma Solutions, Lactobio A/S, Archer Daniels Midland Company, Kirin Holdings Company, Limited, Bioflag Group, Probiotics Australia Pty., Ltd., Lesaffre, Otemchi Biotechnologies Pte. Ltd., SILAB, Mitsubishi Corporation, GeneFerm Biotechnology Co., Ltd., and KOREA BeRM co., Ltd.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the postbiotic market analysis from 2021 to 2031 to identify the prevailing postbiotic market opportunities.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights buyers' and suppliers' potency to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the postbiotic market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global postbiotic market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Form

Powder
Liquid
Others

By Application

Personal Care and Cosmetics
Food and Beverage
Animal Feed
Pharmaceuticals
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa
Key Market Players
- Adare Pharma Solutions
- Church & Dwight Co., Inc.
- Danish Agro
- woresan GmbH
- ILDONG HOLDINGS CO., LTD.
- Sami-Sabinsa Group Limited
- Lesaffre
- Bioflag Group
- Archer Daniels Midland Company
- Otemchi Biotechnologies Pte. Ltd.
- GeneFerm Biotechnology Co., Ltd.
- Mitsubishi Corporation
- Probiotics Australia Pty., Ltd.
- Cargill, Incorporated
- Lactobio A/S
- SILAB
- KOREA BeRM co., Ltd
- Novachem SRL
- Kirin Holdings Company, Limited
- Lamberti S.p.A.

Product Code: A31027

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: POSTBIOTIC MARKET, BY FORM

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Powder
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3 Liquid
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
4.4 Others
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country

CHAPTER 5: POSTBIOTIC MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Personal Care and Cosmetics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3 Food and Beverage
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
5.4 Animal Feed
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
5.5 Pharmaceuticals
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country

CHAPTER 6: POSTBIOTIC MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Form
- 6.2.3 North America Market size and forecast, by Application
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Key market trends, growth factors and opportunities
  - 6.2.4.1.2 Market size and forecast, by Form
  - 6.2.4.1.3 Market size and forecast, by Application
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Key market trends, growth factors and opportunities
  - 6.2.4.2.2 Market size and forecast, by Form
  - 6.2.4.2.3 Market size and forecast, by Application
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Key market trends, growth factors and opportunities
  - 6.2.4.3.2 Market size and forecast, by Form
  - 6.2.4.3.3 Market size and forecast, by Application
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Form
- 6.3.3 Europe Market size and forecast, by Application
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Key market trends, growth factors and opportunities
  - 6.3.4.1.2 Market size and forecast, by Form
  - 6.3.4.1.3 Market size and forecast, by Application
  - 6.3.4.2 France
  - 6.3.4.2.1 Key market trends, growth factors and opportunities
  - 6.3.4.2.2 Market size and forecast, by Form
  - 6.3.4.2.3 Market size and forecast, by Application
  - 6.3.4.3 UK
  - 6.3.4.3.1 Key market trends, growth factors and opportunities
  - 6.3.4.3.2 Market size and forecast, by Form
  - 6.3.4.3.3 Market size and forecast, by Application
  - 6.3.4.4 Italy
  - 6.3.4.4.1 Key market trends, growth factors and opportunities
  - 6.3.4.4.2 Market size and forecast, by Form
  - 6.3.4.4.3 Market size and forecast, by Application
  - 6.3.4.5 Spain
  - 6.3.4.5.1 Key market trends, growth factors and opportunities
  - 6.3.4.5.2 Market size and forecast, by Form
  - 6.3.4.5.3 Market size and forecast, by Application
  - 6.3.4.6 Netherlands
  - 6.3.4.6.1 Key market trends, growth factors and opportunities
  - 6.3.4.6.2 Market size and forecast, by Form
  - 6.3.4.6.3 Market size and forecast, by Application
  - 6.3.4.7 Rest of Europe
  - 6.3.4.7.1 Key market trends, growth factors and opportunities
  - 6.3.4.7.2 Market size and forecast, by Form
  - 6.3.4.7.3 Market size and forecast, by Application
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Form
- 6.4.3 Asia-Pacific Market size and forecast, by Application
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 China
  - 6.4.4.1.1 Key market trends, growth factors and opportunities
  - 6.4.4.1.2 Market size and forecast, by Form
  - 6.4.4.1.3 Market size and forecast, by Application
  - 6.4.4.2 Japan
  - 6.4.4.2.1 Key market trends, growth factors and opportunities
  - 6.4.4.2.2 Market size and forecast, by Form
  - 6.4.4.2.3 Market size and forecast, by Application
  - 6.4.4.3 India
  - 6.4.4.3.1 Key market trends, growth factors and opportunities
  - 6.4.4.3.2 Market size and forecast, by Form
  - 6.4.4.3.3 Market size and forecast, by Application
  - 6.4.4.4 South Korea
  - 6.4.4.4.1 Key market trends, growth factors and opportunities
  - 6.4.4.4.2 Market size and forecast, by Form
  - 6.4.4.4.3 Market size and forecast, by Application
  - 6.4.4.5 Australia
  - 6.4.4.5.1 Key market trends, growth factors and opportunities
  - 6.4.4.5.2 Market size and forecast, by Form
  - 6.4.4.5.3 Market size and forecast, by Application
  - 6.4.4.6 Rest of Asia-Pacific
  - 6.4.4.6.1 Key market trends, growth factors and opportunities
  - 6.4.4.6.2 Market size and forecast, by Form
  - 6.4.4.6.3 Market size and forecast, by Application
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Form
- 6.5.3 LAMEA Market size and forecast, by Application
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Latin America
  - 6.5.4.1.1 Key market trends, growth factors and opportunities
  - 6.5.4.1.2 Market size and forecast, by Form
  - 6.5.4.1.3 Market size and forecast, by Application
  - 6.5.4.2 Middle East
  - 6.5.4.2.1 Key market trends, growth factors and opportunities
  - 6.5.4.2.2 Market size and forecast, by Form
  - 6.5.4.2.3 Market size and forecast, by Application
  - 6.5.4.3 Africa
  - 6.5.4.3.1 Key market trends, growth factors and opportunities
  - 6.5.4.3.2 Market size and forecast, by Form
  - 6.5.4.3.3 Market size and forecast, by Application

CHAPTER 7: COMPANY LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments

CHAPTER 8: COMPANY PROFILES

8.1 Sami-Sabinsa Group Limited
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
8.2 woresan GmbH
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
8.3 Novachem SRL
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
8.4 ILDONG HOLDINGS CO.,LTD.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
8.5 Church & Dwight Co., Inc
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
8.6 Danish Agro
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
8.7 Lamberti S.p.A.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
8.8 Cargill, Incorporated
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
8.9 Adare Pharma Solutions
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
8.10 Lactobio A/S
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
8.11 Archer Daniels Midland Company
- 8.11.1 Company overview
- 8.11.2 Company snapshot
- 8.11.3 Operating business segments
- 8.11.4 Product portfolio
- 8.11.5 Business performance
- 8.11.6 Key strategic moves and developments
8.12 Kirin Holdings Company, Limited.
- 8.12.1 Company overview
- 8.12.2 Company snapshot
- 8.12.3 Operating business segments
- 8.12.4 Product portfolio
- 8.12.5 Business performance
- 8.12.6 Key strategic moves and developments
8.13 Bioflag Group
- 8.13.1 Company overview
- 8.13.2 Company snapshot
- 8.13.3 Operating business segments
- 8.13.4 Product portfolio
- 8.13.5 Business performance
- 8.13.6 Key strategic moves and developments
8.14 Probiotics Australia Pty., Ltd.
- 8.14.1 Company overview
- 8.14.2 Company snapshot
- 8.14.3 Operating business segments
- 8.14.4 Product portfolio
- 8.14.5 Business performance
- 8.14.6 Key strategic moves and developments
8.15 Lesaffre
- 8.15.1 Company overview
- 8.15.2 Company snapshot
- 8.15.3 Operating business segments
- 8.15.4 Product portfolio
- 8.15.5 Business performance
- 8.15.6 Key strategic moves and developments
8.16 Otemchi Biotechnologies Pte. Ltd.,
- 8.16.1 Company overview
- 8.16.2 Company snapshot
- 8.16.3 Operating business segments
- 8.16.4 Product portfolio
- 8.16.5 Business performance
- 8.16.6 Key strategic moves and developments
8.17 SILAB
- 8.17.1 Company overview
- 8.17.2 Company snapshot
- 8.17.3 Operating business segments
- 8.17.4 Product portfolio
- 8.17.5 Business performance
- 8.17.6 Key strategic moves and developments
8.18 Mitsubishi Corporation
- 8.18.1 Company overview
- 8.18.2 Company snapshot
- 8.18.3 Operating business segments
- 8.18.4 Product portfolio
- 8.18.5 Business performance
- 8.18.6 Key strategic moves and developments
8.19 GeneFerm Biotechnology Co., Ltd.
- 8.19.1 Company overview
- 8.19.2 Company snapshot
- 8.19.3 Operating business segments
- 8.19.4 Product portfolio
- 8.19.5 Business performance
- 8.19.6 Key strategic moves and developments
8.20 KOREA BeRM co.,Ltd
- 8.20.1 Company overview
- 8.20.2 Company snapshot
- 8.20.3 Operating business segments
- 8.20.4 Product portfolio
- 8.20.5 Business performance
- 8.20.6 Key strategic moves and developments